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Although several types of programmed cell death (PCD) have
been characterized, apoptosis is considered the predominant mode
of PCD that occurs under physiological conditions. The relevance
of apoptosis in oncology appears evident when considering that
oncogenic transformation can be determined by a defect in apop-
tosis. Moreover, one of the aims of anti-tumour chemotherapy is to
obtain tumour regression by stimulating apoptosis in cancer cells
as specifically as possible. One possible way to induce apoptosis
in cancer cells is by blocking signal transduction of growth factors
and hormone receptors. In fact, some tumour cells, such as in the
prostate and breast cancers, express receptors for endogenous
hormones, and these findings have led to the development and
clinical use in cancer therapy of molecules endowed with anti-
hormone properties. The anti-oestrogen tamoxifen (TAM) was the
first drug clinically developed in this class of compounds and has
been widely and successfully utilized in the treatment of breast
cancer. For this disease, large clinical trials have indicated that a
favourable response to adjuvant therapy with this drug is present
also in oestrogen receptor (ER)-poor tumours (reviewed in
Jaiyesimi et al, 1995), thereby suggesting that at least a part of the
antineoplastic action may not be related to the anti-hormone
properties of TAM. This hypothesis gains support from early data
of Perry et al (1995) showing that at a clinically achievable
dosage, TAM reduces the growth and induces apoptosis in ER-
negative cell lines. More recently, our group has demonstrated in
an ER-negative model that TAM facilitates apoptosis induced by
docetaxel (Ferlini et al, 1997), whose apoptotic activity is
dependent on the stabilization of the microtubule network and
inactivation via phosphorylation of the antiapoptotic bcl-2 protein
(Haldar et al, 1996).
In principle, several in vitro properties of TAM could be held
responsible for its pro-apoptotic role in ER-negative cells: calcium
channel blocking activity (Lopes et al, 1990), inhibition of protein
kinase C (Issandou et al, 1990), up-regulation of c-myc expression
(Kang et al, 1996) or induction of oxidative stress (Gundimeda et
al, 1996; Ye et al, 1996). In particular, this last point is intriguing
as previous studies have indicated TAM to be an antioxidant agent
(Wiseman et al, 1990, 1993).
The aim of the present work was to identify an ER-independent
pathway that could explain, at least in part, the antineoplastic
activity of TAM reported in ER-negative cells and ER-poor
tumours. The results indicate that TAM acts as a potent pro-
oxidative agent able to induce activation of the nuclear transcrip-
tion factor kappa B (NF-kB), thereby establishing a theoretical
ground to design new drug approaches combining TAM with
chemotherapy.
MATERIALS AND METHODS
Drugs
TAM stock solutions (10 mM) were made in absolute ethanol, and
were used at concentrations ranging from 0.1 to 10 mM. The final
ethanol concentration never exceeded 1% (v/v), in control and
treated samples.
Cell cultures
The cell lines used in this study were the ovarian cancer A2780
cells and the T-leukaemic Jurkat. For all the cell lines, RPMI-1640
was used as culture medium and supplemented with 10% fetal calf
serum (FCS) and 200 U ml–1 penicillin. A2780 adherent cells,
propagated as monolayer culture in 75-cm2 tissue-culture flasks,
were trypsinized weekly and plated at a density of 8´104 cells ml–1.
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ItalyJurkat cells (growing in suspension) were seeded at 2–3´105 cells
ml–1 and split in a ratio of 1:3 every day. All cultures were incubated
at 37°C under 5% carbon dioxide/95% air in a high humidity atmos-
phere. Both cell lines used were ER negative (Berman et al, 1991).
Growth experiments
Cells were plated in six-well flat-bottom plates (Falcon, Lincoln
Park, NJ, USA) at a concentration of 1´105 cells ml–1 in complete
medium. After 24 h, the medium was replaced with fresh medium
containing TAM and incubation was continued up to 72 h. Control
cells were treated with vehicle alone. Quadruplicate counts of trip-
licate cultures were performed at each time point (24, 48 and 72 h).
[3H]Thymidine uptake
Jurkat cells were plated in 96-well flat-bottom plates (Costar,
Cambridge, MO, USA) at a concentration of 1´105 cells ml–1 in
200 ml of complete medium containing TAM and incubated from 6
to 72 h. Control cells were treated with vehicle alone. In the last 6 h
of culture, 0.5 mCi per well of [3H]thymidine (Amersham Italia,
Milan, Italy) was added. Plates were harvested and counted using
the Betaplate system (Wallac Oy, Turku, Finland). Results are
expressed as c.p.m. means of six replicate cultures. Experimental
data was considered acceptable if the standard deviation was less
than 15% of the c.p.m. mean calculated using six replicate samples.
Fluorescent probes and flow cytometry
The redox state was investigated using 5-chloromethylfluorescein
diacetate (CMFDA, Molecular Probes, Eugene, OR, USA) and 2-7-
dichlorodihydrofluorescein diacetate (DCHFDA, Molecular Probes).
Cells were incubated at 37°C with 10 nM CMFDA used as an indi-
cator of intracellular thiol levels (Poot et al, 1991). After 20 min,
samples were washed once and then resuspended in phosphate-
buffered saline (PBS) containing 4 mg ml–1 ethidium bromide (EB), a
probe for plasma membrane status. A parallel culture was stained at
37°C in complete medium with 5 mMDCHFDA, an indicator of reac-
tive oxygen species (ROS) production (Bass et al, 1983). After 1 h of
incubation, cells were washed once and then resuspended in PBS
containing 5 mM DCHFDA and 4 mg ml–1 EB. Dual-colour flow
cytometry was performed by collecting the fluorescence of
DCHFDA and CMFDA in the green and that of EB in the orange
emissions. Electronic colour compensation was used to compensate
for crossover between fluorochromes. Fluorescence of EB served to
gate out dead cells. Up to 15 000 events were acquired using Lysis II
software (Becton Dickinson Immunocytometry Systems, San Jose,
CA, USA) on a FACScan (Becton Dickinson) cytometer equipped
with a standard filter set for green (530/30 nm) and orange emissions
(585/42 nm). Fluorescence signals were acquired in log mode.
Results are expressed as the mean channel of fluorescence intensity.
Cell cycle analysis
Cells were plated in the specific medium supplemented as above.
After 24 h, the medium was replaced with fresh medium
containing TAM or vehicle alone. After various times of culture
(from 6 h to 72 h), cells were harvested and nuclei isolated and
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Table 1 Cell cycle analysis of Jurkat cells cultured in the presence of TAM
Time of G1 SG 2 DNA
exposure (h) fragmentationa
Control 6 55.8 37.7 6.5 8.64
TAM 0.1 mM 55.3 39 5.7 6.98
TAM 1 mM 54.6 39 6.4 5.91
TAM 10 mM 52.3 40.2 7.5 6.89
Control 24 76.1 16.2 7.7 9.13
TAM 0.1 mM 75.9 16.2 7.9 8.87
TAM 1 mM 76.4 16.3 7.3 9.28
TAM 10 mM 77.3 12.9 9.8 16.98
Control 48 59.3 28.5 12.2 7.82
TAM 0.1 mM 60.1 28.2 11.7 7.67
TAM 1 mM 61 26.6 12.5 6.55
TAM 10 mM 75.2 14.4 10.3 26.19
Control 72 54.9 32.8 12.3 3.12
TAM 0.1 mM 55.1 32.6 12.3 3.83
TAM 1 mM 54.5 33.7 11.8 3.34
TAM 10 mM 71.7 17.8 10.5 27.66
aDNA fragmentation was excluded by cell cycle analysis.
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Figure 1 Cell count analysis performed in Jurkat cells after (A) 24, (B) 48,
and (C) 72 h of culture in the presence of TAM (concentration range 0.1–
10 mM). Viable cells ( ) and apoptotic cells ( ) were counted in parallel
preparations. Standard deviation was less than 5% for each count and has
been omittedstained using a solution containing 0.1% (w/v) sodium citrate,
0.1% (v/v) Nonidet-P40, 4 mM EDTA and 50 mg ml–1 of propidium
iodide (PI) as a DNA dye (Ferlini et al, 1996). Incubation of the
cells with the staining solution lasted a minimum of 24 h at 4°C.
Flow cytometric DNA analysis was performed by acquiring a
minimum of 20 000 nuclei. DNA fluorescence was collected in
linear and log mode and pulse signal processing was used to set a
doublet discrimination gate. Cell cycle analysis was performed using
the Multicyle software package (Phoenix, San Diego, CA, USA).
Electrophoretic mobility shift assay (EMSA)
About 20 ´ 106 cells were resuspended in 200 ml high-salt buffer
(20 mMHepes, pH 7.9, 400 mMsodium chloride, 1 mMEDTA, 1 mM
EGTA, 1 mM DTT, 1 mM PMSF, 0.6% Nonidet-P40). After a 20 min
incubation on ice, the samples were centrifuged and the supernatant
was stored in aliquots at –70°C. The protein concentration was deter-
mined with the Bio-Rad Protein Assay (BioRad Laboratories,
Hercules, CA, USA). Equal amounts of the extracts (15 mg) were
added to 6 mg of poly(dI–dC) as a non-specific DNA competitor in
1´ binding buffer (10 mM Hepes, pH 7.5, 60 mM potassium chloride,
1m M EDTA, 1 mM DTT, 10% glycerol). After a 15 min incubation
on ice, 20 000 c.p.m. of the NF-kB or AP-1 specific probes were
added and incubated with the reaction mixture for 20 min at room
temperature. Samples were loaded on a 6% polyacrylamide gel and
run in 0.3 ´ TBE buffer at 150 V. Gels were exposed in an Instant
Imager Electronic Autoradiography Instrument (Packard Instrument,
Meriden, CT, USA) and were quantified by the Imager program
provided with the instrument. The sequences of the oligonucleotides
were as described in Los et al (1995).
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Figure 2 Representative morphological analysis without (A) or with (B) DNA staining of Jurkat cells after 72 h of culture in the presence of TAM (concentration
range 0.1–10 mM). (A) (magnification 100´) control cells are characterized by growth in clumps forming a large-meshed net on the plate. At the lowest TAM dose
(0.1 mM), clumps appear slightly larger as an indication of the increased proliferative activity. At the highest TAM dose, cell clumping is no longer visible as
proliferative activity is severely impaired. (a) Control; (b) TAM 0.1 mM; (C) TAM 1 mM; (D) TAM 10 mM. (B) (magnification 1000´) features of nuclear apoptosis
with extremely condensed and polarized chromatin (arrows) and nuclear blebbing (double arrows). (e) Control; (f) TAM 10 mM
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dBcl-2 Western blots
The pellet obtained from 10 ´ 106 cells was washed twice in 1´ PBS
and then dissolved in lysis buffer containing 20 mM tris-HCl,
pH 7.4, 100 mM sodium chloride, 5 mM magnesium chloride, 1%
Nonidet P-40, 0.5% sodium deoxycholate, 2 U ml–1 of the kallikrein
inhibitor aprotinin. After addition of sodium dodecyl sulphate
(SDS) sample buffer, 200 mg total proteins were separated by 15%
sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) and electroblotted onto PVDF (Millipore, Bedford, MA,
USA). The membranes were incubated with 6% non-fat dry milk in
1´ TBST (0.1 M trizma base, 0.15 M sodium chloride, 0.05% Tween
20, pH 7.4) for blocking and then with a 1:100 dilution of the mouse
monoclonal anti-Bcl-2 antibody clone 124 (Dako, Glostrup,
Denmark) in 1´ TBST. The membranes were then incubated with
a biotinylated secondary antibody (ABC Vectastain Elite, Vector
Labs, Burlingame, CA, USA) and detection was performed with the
DAB kit (Vector Labs) in 1´ TBST. Images of the blots were
acquired with a CCD camera and quantification of the Bcl-2 bands
were performed by Phoretix 1D Gel Analysis software (Phoretix
International, Newcastle upon Tyne, UK).
Morphological analysis
Morphological features of apoptosis were assessed by scoring
control and TAM-treated cultures (concentration range 0.1–10 mM)
seeded in six-well flat bottom plates (Costar) using an inverted
Diavert fluorescence microscope (Leica, Wetzlar, Germany).
Cultures were fixed in 70% cold ethanol, stored overnight at
–20°C, resuspended in PBS containing 50 mg ml–1 ribonuclease
(Sigma) and stained with the green DNA dye Yoyo-1 (Molecular
Probes) at a concentration of 4 mM. Samples were then examined
to identify cell with features of apoptotic chromatin as previously
described (Ferlini et al, 1996). Image analysis was performed
using the IAS2000 system (Delta Sistemi, Rome, Italy).
RESULTS
ER-independent induction of proliferation/apoptosis
Jurkat cells were cultured in the presence of TAM (concentration
range 0.1–10 mM) for up to 72 h. After 24, 48 and 72 h, cell count
analysis demonstrated (Figure 1) a slight proliferative effect at the
lowest TAM dose (0.1 mM). In contrast, a decrease in live cells
occurred when TAM was used at 10 mM (Figure 1). To evaluate
whether the observed effect was linked to a perturbation in cell
cycle, DNA content analysis was performed after 6, 24, 48 and
72 h (Table 1). Results showed that an appreciable cytokinetic
effect was present only in the presence of 10 mM TAM and that a
cell cycle arrest in the Gl/S boundary was evident starting from 
8 h. A concomitant increase of DNA fragmentation, suggestive for
the occurrence of late apoptosis, was also evident (Table 1). To
confirm the presence of apoptosis, morphological analysis was
performed and cells with features of apoptotic chromatin, such as
condensation and blebbing (Figure 2), were counted after staining
with the green DNA dye Yoyo-1. Results confirmed (Figure 1) that
a stable (during time course) increase of apoptotic cells was
present at the highest concentration of TAM (10 mM). Remarkably,
it is worth noting that at this dosage a reliable antiproliferative
effect was not visible until 72 h because the sum of apoptotic and
live cells in TAM-treated samples did not detectably decrease with
respect to control cells after 24 and 48 h of culture.
In order to assess DNA synthesis rate in Jurkat cells cultured in
the presence of TAM (concentration range 0.1–10 mM), [3H]-
thymidine uptake was evaluated after 6, 24, 48 and 72 h of culture
(data not shown). Up to 24 h, no significant changes were evident
in all culture conditions. Conversely, after 48 and 72 h a slight
increase in [3H]thymidine uptake was noticed for 0.1 mM of TAM,
whereas at 10 mM [3H]thymidine uptake decreased remarkably.
Taking all these data together, we conclude that TAM is able to
induce either cell proliferation or apoptosis depending on the dose,
thereby resembling other mediators of oxidative stress (Murrell et
al, 1990; Rao et al, 1992; Los et al, 1995).
Redox metabolism in TAM-treated cells
As a direct approach to the question of whether TAM is able to
modulate redox metabolism, ROS production and intracellular
thiol level were evaluated using flow cytometry in two human
cancer cells: the T-leukaemic Jurkat and the ovarian cancer A2780
cells. Such analysis was performed after 1, 2, 6 and 18 h of culture.
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Figure 3 Flow cytometric analysis of redox metabolism in Jurkat cells after
1, 2, 6 and 18 h of culture in the presence of 0.1 mM ( ), 1 mM ( ) and 10 mM
(n n) of TAM. Control cells were treated with vehicle alone (n). ROS
production (A) and thiol level (B) were monitored using the fluorescent
probes DCHFDA and CMFDA respectively. The same experiment was
repeated three times with similar resultsIn Jurkat cells, an increased ROS production was noticed starting
from 2 h of culture at the highest dose of TAM (10 mM) (Figure
3A). Remarkably, such increase in ROS production was combined
with a decreased thiol level that was present at the same TAM
concentration starting from 1 h (Figure 3B). Similar effects
(increased ROS production and decreased thiol level), even if less
evident, were present also at the lower TAM concentrations (0.1
and 1 mM). Similar results were obtained using A2780 cells (not
shown). This suggests that TAM was able to behave as a pro-
oxidative agent, sequentially inducing thiol consumption and
oxidative stress in a dose-dependent manner.
Modulation of transcription factor activity induced by
TAM
At least two well-defined transcription factors, NF-kB and AP-1,
are regulated by intracellular redox status (Sen et al, 1996). Thus,
we evaluated the DNA-binding activity of these two transcription
factors using EMSA in both ER-negative cancer cell lines upon a
short exposure (range 1–4 h) to 10 mM of TAM, the dose inducing
maximal oxidative stress and apoptosis. In Jurkat cells, an
increased DNA-binding activity was documented for NF-kB,
whereas the activity of AP-1 remained essentially unaffected
(Figure 4). The DNA-binding activity of NF-kB peaked in Jurkat
cells after 3 h of TAM treatment with a maximum increase up to
3.7-fold compared with the control value. Similarly, A2780 cells
showed an increase of the DNA-binding activity of NF-kB up to
3.2-fold after 3 h of culture in the presence of TAM (Figure 4),
without an appreciable change of DNA binding activity of AP-1.
Bcl-2 expression and phosphorylation
To better clarify the biochemical mechanism underlying TAM-
induced apoptosis, we looked at the expression and activation
status of the antiapoptotic bcl-2 protein. Jurkat cells were treated
either with the vehicle alone (ethanol 1%) or with 10 mM TAM for
6, 24, 48 and 72 h. An additional control was carried out using
Jurkat cells cultured in the presence of 1 mM paclitaxel for 24 h to
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Figure 4 DNA-binding activity of the transcription factors NF-kB (A and C) and AP-1 (B and D) in A2780 (A and B) and Jurkat cells (C and D). Lanes 1–4
represent control cells (only vehicle ethanol 1%) after 1, 2, 3 and 4 h of culture respectively. Lanes 5–8 are TAM-treated cells (10 mM) after 1, 2, 3 and 4 h of
culture. Specificity of DNA binding was verified using a ten- and 100-fold excess of unlabelled oligonucleotide (lanes 9 and 10 respectively)induce the phosphorylated slow isoform of bcl-2 protein. Results
clearly indicated that TAM was unable to down-regulate the
expression of bcl-2 protein or to induce its functional inactivation
by phosphorylation (Figure 5), thereby suggesting for TAM that
oxidative stress, thiol depletion and activation of NF-kB are not
involved in the regulation of bcl-2 activity.
DISCUSSION
Large clinical trials have demonstrated the efficacy of the anti-
oestrogen TAM in the adjuvant therapy of breast cancer. Although
the effect of TAM in terms of recurrence-free survival is maximum
in ER-rich tumours, a significant favourable effect was detected
also in ER-poor cancers (reviewed in Jaiyesimi et al, 1995).
Interestingly, responses to TAM have been observed also in
cancers not derived from oestrogen-sensitive tissues, such as
glioma (Couldwell et al, 1994) and melanoma (McClay et al,
1993). Perry et al (1995) proposed a possible explanation for these
data by reporting that TAM is able to induce apoptosis via an ER-
independent pathway. In this paper, we furnish a biochemical basis
for the TAM-induced apoptosis in ER-negative models, by demon-
strating that TAM generates ROS production and thiol depletion in
a dose-dependent manner. The balance between ROS and cellular
thiol levels plays a pivotal role in regulating cell cycle progression
and apoptosis. It has been previously shown that mitogenic stimu-
lation of cells induces a rapid and transient increase of ROS
production (Murrell et al, 1990; Rao et al, 1992; Los et al, 1995),
suggesting that a short pro-oxidative shift provides a signal to
enter the cell cycle. This oxidative burst, with its consequent gene
expression, must be balanced and counteracted by endogenous
antioxidants. In keeping with this view, TAM at 0.1 mM stimulates,
in a slight but consistent way, DNA synthesis and cell proliferation
as indicated by cell counts and [3H]thymidine uptake. Conversely,
increasing the dose of TAM leads to opposite effects along the
same pathway. In fact, at 10 mM of TAM, cell proliferation is not
immediately blocked, rather a higher number of cells enter into the
apoptotic pathway after an initial progression into the proliferative
cycle perhaps as a consequence of excessive ROS production and
a non-sustainable thiol depletion. Only later, in surviving cells, the
proliferative compartment is clearly reduced and the cell cycle is
frozen at the Gl/S boundary.
As in other models of oxidative stress, TAM treatment increases
ROS until a threshold level is attained for the activation of NF-kB,
which then translocates into the cell nucleus thereby promoting
transcription of a package of dependent genes. Among these, NF-
kB contributes to the control of c-myc activity, an oncogene essen-
tial for the cell proliferation/apoptosis programme (Janssen et al,
1995). In this scenario, our data are in good agreement with Kang et
al (1996), who reported that TAM regulates c-myc expression at the
transcriptional level: low enhancement of c-myc results in the cell
cycle progression, whereas higher enhancement led to cytostasis
and apoptosis. Thus, it appears that oxidative stress, NF-kB activa-
tion, c-myc expression and the proliferation/apoptosis programme
are sequentially involved in the same pathway by TAM treatment.
In contrast to the oxidative agent okadaic acid (Haldar et al,
1995), ROS production upon TAM treatment is unable to produce
the serine-phosphorylated isoform of bcl-2 protein that, in this
inactivated form, can no longer prevent lipid peroxidation and
apoptosis (Hockenbery et al, 1993). Moreover, a down-regulation
of the bcl-2 protein does not appear to be involved in the induction
of apoptosis upon TAM treatment.
There are several reports suggesting that TAM may have syner-
gistic effect when used in combination with different chemothera-
peutic agents, including doxorubicin (De Vincenzo et al, 1996),
taxanes (Ferlini et al, 1997) and cisplatin (McClay et al, 1993).
Although it has been proposed that this chemosensitizing activity
of TAM may be due to an inhibition of P-glycoprotein function
(Kirk et al, 1993; Leonessa et al, 1994), our group (De Vincenzo et
al, 1996) and others (Kang et al, 1993) previously failed to demon-
strate this interaction in multidrug resistant (MDR)-bearing human
cancer cells. Moreover, TAM potentiates the anti-tumour effects of
taxanes also in MDR-negative cancer cell lines (Ferlini et al, 1997).
As far as cisplatin is concerned, none of the currently known mech-
anisms of resistance seem to be influenced by TAM (McClay et al,
1996). Massive apoptosis in our ER-negative models is present at
TAM concentrations probably not obtainable in vivo (10 mM). In
contrast, undoubtedly oxidative stress has been observed at lower
concentrations (< 1 mM), surely obtainable in patients. This ability
of TAM to influence cellular redox metabolism may contribute, at
least in part, to the positive interaction between TAM and
chemotherapeutics: (i) the addition of TAM to doxorubicin, a
potent pro-oxidative agent, produces the same effect observed at
higher doses of the anthracyclinic drug (De Vincenzo et al, 1995);
(ii) the interaction of TAM with cisplatin may be due to the fact that
oxidative stress induced by TAM exhausts intracellular thiol levels
including glutathione, thereby decreasing cellular detoxifying
ability and resistance to platinum compounds (Gosland et al, 1996);
(iii) the entry into the cell cycle induced by TAM may sensitize
cells to the block in M-phase generated by taxanes. Further experi-
mental work is now needed to test this hypothesis.
In summary, TAM is able to induce oxidative stress, NF-kB
modulation and apoptosis of ER-negative human cancer cells. The
knowledge of these properties of TAM will contribute to a better
understanding of the complex pharmacology of this molecule and
consequently to outline the rationale for new clinical protocols in
which TAM could be used to maximize the effects of chemotherapy.
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